e5239b325b8f1dbe6d9e1f7d78cd915169f27b3a
mspeir
  Tue Feb 25 08:19:33 2025 -0800
adding thank you to end of AlphaMissense announcement, refs #32269

diff --git src/hg/htdocs/goldenPath/newsarch.html src/hg/htdocs/goldenPath/newsarch.html
index bfc5a0eec5f..580640303e2 100755
--- src/hg/htdocs/goldenPath/newsarch.html
+++ src/hg/htdocs/goldenPath/newsarch.html
@@ -124,30 +124,34 @@
 <ul>
   <li><a target="_blank"
   href="/cgi-bin/hgTrackUi?db=hg38&g=alphaMissense&position=default">AlphaMissense
   on hg38/GRCh38</a></li>
   <li><a target="_blank"
   href="/cgi-bin/hgTrackUi?db=hg19&g=alphaMissense&position=default">AlphaMissense
   on hg19/GRCh37</a></li>
 </ul>
 <p>
 To learn more about the AlphaMissense dataset, please see the
 publication by <a
 href="https://www.science.org/doi/full/10.1126/science.adg7492"
 target="_blank">Cheng et al. Science. 2023.</a>
 </p>
 
+<p>
+We would like to thank Google DeepMind for making the data available. We would also like to thank
+Jeltje van Baren and Matthew Speir for their efforts on this release.</p>
+
 <a name="021425"></a>
 <h2>Feb. 14, 2025 &nbsp;&nbsp; CIViC track for hg19 and hg38 is now available</h2>
 <p>
 We are excited to announce the release of the CIViC track for <a target="_blank"
 href="/cgi-bin/hgTrackUi?db=hg19&g=civic&position=default">hg19/GRCh37</a> and
 <a href="/cgi-bin/hgTrackUi?db=hg38&g=civic&position=default" target="_blank">hg38/GRCh38</a>.
 The <a target="_blank" href="https://civicdb.org/welcome">
 Clinical Interpretation of Variants in Cancer</a> (CIViC) is an online database of clinically
 relevant variant interpretations from expert- and crowd-sourced peer-reviewed literature, clinical
 trials, and some conference abstracts. The details page for a feature will list diseases and
 therapies that have been associated with a genomic variant. Visiting the CIViC page for a variant
 will allow browsing the Molecular Profiles associated with that variant, and in turn each Molecular
 Profile shows the Clinical Evidence and Assertions for various diseases and therapies.
 </p>